| Using big data from health records from four countries to evaluate chronic disease outcomes: a study in 114 364 survivors of myocardial infarction E Rapsomaniki, M Thuresson, E Yang, P Blin, P Hunt, SC Chung, ... European Heart Journal–Quality of Care and Clinical Outcomes 2 (3), 172-183, 2016 | 130 | 2016 |
| Prevalence, management and outcomes of medically complex vulnerable elderly patients with urinary incontinence in the United States X Luo, CC Chuang, E Yang, KH Zou, AL Araiza, T Bhagnani International Journal of Clinical Practice 69 (12), 1517-1524, 2015 | 37 | 2015 |
| Healthcare resource utilization of second-generation long-acting injectable antipsychotics in schizophrenia: risperidone versus paliperidone palmitate K Joshi, X Pan, R Wang, E Yang, C Benson Current Medical Research and Opinion 32 (11), 1873-1881, 2016 | 26 | 2016 |
| Clinical and economic outcomes among elderly myocardial infarction survivors in the United States E Yang, M Stokes, S Johansson, C Mellström, E Magnuson, DJ Cohen, ... Cardiovascular Therapeutics 34 (6), 450-459, 2016 | 22 | 2016 |
| International comparison of outcomes among 140,880 patients stable after acute MI; real world evidence from electronic health and administrative records E Rapsomaniki, M Thuresson, E Yang European society of Cardiology Congress, barcelona, spain 30, 2014 | 12 | 2014 |
| Real-world clinical and economic outcomes and the role of bevacizumab in patients with non–Small-Cell lung cancer with liver metastases WB Wong, N Wu, E Yang, J Davies, YK Chae Journal of oncology practice 15 (10), e878-e887, 2019 | 11 | 2019 |
| Health and functional status, health events, use of healthcare services and costs associated with overactive bladder among the medically complex vulnerable elderly in the US. LX Chuang CC, Yang E, Zou KH, Araiza A, Wang A International Journal of Clinical Practice, 2018 | 5* | 2018 |
| Early experience with ocrelizumab: patient characteristics from a large insurance claims database NJ Engmann, E Yang, L Julian, WS Yeh, J Whiteley MULTIPLE SCLEROSIS JOURNAL 24, 963-964, 2018 | 4 | 2018 |
| Re-evaluating an algorithm to identify multiple sclerosis relapse in insurance claims databases E Yang, NJ Engmann, WS Yeh, L Julian MULTIPLE SCLEROSIS JOURNAL 24, 570-571, 2018 | 3 | 2018 |
| Real-world adherence and persistence with anaplastic lymphoma kinase inhibitors in non-small cell lung cancer SO Apar Kishor Ganti, Chia-Wei Lin, Erru Yang, William Wong Journal of Managed Care and Specialty Pharmacy, 2021 | 2* | 2021 |
| Real-world outcomes with ocrelizumab compared with other disease-modifying therapies in US commercial claims databases (2911) NJ Engmann, D Sheinson, E Yang, D Fiore, E Alvarez, KV Nair, ... Neurology 94 (15 Supplement), 2020 | 1 | 2020 |
| HSR20-084: real-world adherence and persistence of ALK inhibitors in non-small cell lung cancer (NSCLC) AK Ganti, S Ogale, E Yang, W Wong Journal of the National Comprehensive Cancer Network 18 (3.5), HSR20-084 …, 2020 | 1 | 2020 |
| Real-world evidence of the impact of prior antibiotic exposure on immune checkpoint inhibitor outcomes in patients with metastatic urothelial cancer. JH Hoffman-Censits, LC Harshman, M Metcalf, S Abou Alaiwi, CS Meyer, ... Journal of Clinical Oncology 38 (6_suppl), 452-452, 2020 | 1 | 2020 |
| Assessment of the burden of multiple sclerosis on family caregivers by patient disability severity E Yang, W Yeh, NJ Engmann, Y Xu, L Julian Value in Health 21, S208, 2018 | 1 | 2018 |
| Healthcare resource utilization and cost of overactive bladder among the medically complex vulnerable elderly in the United States C Chuang, E Yang, K Zou, A Araiza, A Wang, X Luo JOURNAL OF THE AMERICAN GERIATRICS SOCIETY 63, S72-S72, 2015 | 1 | 2015 |
| Health outcomes and functional status of overactive bladder among the medically complex vulnerable elderly in the United States C Chuang, E Yang, K Zou, A Araiza, A Wang, X Luo JOURNAL OF THE AMERICAN GERIATRICS SOCIETY 63, S62-S62, 2015 | 1 | 2015 |
| Health care resource utilization and costs associated with various stages of chronic kidney disease among type 2 diabetes mellitus patients CC Chuang, E Lee, E Yang, A Tawah, S Ghosh, SY Chen Value in Health 17 (3), A244-A245, 2014 | 1 | 2014 |
| PRO105 COMPLICATIONS ASSOCIATED WITH CENTRAL VENOUS ACCESS DEVICES IN PATIENTS WITH HEMOPHILIA A (PWHA): A SECONDARY CLAIMS-BASED ANALYSIS C Orji, R Khairnar, AM Patel, E Yang, CS Meyer, IM Abbass Value in Health 23, S348, 2020 | | 2020 |
| Persistence and Adherence to Ocrelizumab Compared with Other Disease-Modifying Therapies for Multiple Sclerosis in US Commercial Claims Databases N Engmann, E Yang, D Fiore, G Pardo MULTIPLE SCLEROSIS JOURNAL 26 (1_ SUPPL), 46-46, 2020 | | 2020 |
| Adherence, persistence and switching patterns of patients initiating ocrelizumab compared to other disease-modifying therapies in the real world (3923) NJ Engmann, E Yang, D Fiore, G Pardo Neurology 94 (15_supplement), 3923, 2020 | | 2020 |
Chien-Chia Chuang, PhDHealth Economics and Value Assessment Dermatology Lead, Senior Director (DUPIXENT), SanofiVerified email at sanofi.com
